Penumbra, Inc. (PEN) vs Insulet Corporation (PODD)
- Penumbra, Inc. PEN 319.20 −0.59%
- Insulet Corporation PODD 146.38 −6.24%
Penumbra, Inc. and Insulet Corporation are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.7B against $10.8B — 1.2× the size. Insulet Corporation trades at the lower P/E: 25.2× against 80.3×. Insulet Corporation grew revenue faster over the last twelve months: 26.5% against 17.0%. Insulet Corporation has the higher net margin (13.5% vs 10.1%) and the higher return on invested capital (18.8% vs 12.7%). Across the 22 metrics below, Insulet Corporation leads on 17 and Penumbra, Inc. on 5.
Valuation
Profitability
| Metric | PEN | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 67.98% | 71.88% | 57.76% |
| Operating margin | 12.13% | 18.43% | (15.07%) |
| Net margin | 10.06% | 13.45% | (14.45%) |
| Free cash flow margin | 12.84% | 8.15% | (3.88%) |
| Return on equity | 10.67% | 28.94% | (10.35%) |
| Return on assets | 8.33% | 13.31% | (17.26%) |
| Return on invested capital | 12.73% | 18.77% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack